- Spring Media
- Posts
- The $10 Billion Industry Nobody Wants to Touch (And the $2.2M Case Study)
The $10 Billion Industry Nobody Wants to Touch (And the $2.2M Case Study)
The Thursday Brain Download
Hey, it's Arik.
Last month, one of our clients generated $2.2M in revenue selling products that most marketing agencies won't even touch.
Their Facebook ads were banned within 48 hours by every other agency they tried, their Google campaigns were shut down for "policy violations," their email marketing was almost nonexistent as three different ESPs dropped them for "prohibited content." Their payment processor even froze their account with zero warning.
Sound familiar?
Welcome to the peptide industry, where the demand is exploding, the profits are insane, but 99% of service providers run away the moment they hear what you're selling.
The Peptide Problem Most People Don't See
Peptides are being quoted by industry experts as the next $10+ billion market. We're talking about growth that could rival the entire vitamin and supplement industry. But there's a catch. Actually, there are about fifty catches.
• Manufacturing costs that are 3-4x higher than regular supplements
• Payment processors ghost you without explanation
• Regulatory compliance requires a team of lawyers
• Supply chain issues can kill your business overnight
• Account bans can wipe out months of work in minutes
Most peptide brands are trapped in this weird purgatory where they have customers literally begging to buy their products, but they can't scale because every platform treats them like criminals.
Why We Built a "Banned Industry" Division
Six months ago, I made what most people thought was a crazy decision. Instead of avoiding peptide brands like every other agency, we decided to go all-in on them.
Why? Because I realized these aren't roadblocks, they're moats. Every challenge that makes peptide marketing "impossible" is also a barrier that keeps out 99% of the competition. The brands that figure out how to navigate this landscape will have the entire market to themselves.
So we didn't just start taking on peptide clients. We’ve been working behind the scenes building an entirely separate division (Spring Peptides) designed specifically to solve every single challenge these brands face.
The $896,520 Meta Campaign That "Shouldn't Exist"
Let me show you what's possible when you actually know how to work in this space.
Remember that client I mentioned who hit $2.2M in revenue? Here's their story:
When they came to us, they had great products, loyal customers, but they were hitting walls everywhere they tried to grow.
They had no clear brand guidelines to create consistent, compelling messaging across their customer journey, and they lacked foundational email infrastructure, including core flows and a well-defined campaign strategy to drive retention and keep their audience informed.
What we did:
We rebuilt their entire business infrastructure from the ground up. Not just marketing, everything.
Email Infrastructure:
We built compliant welcome flows, abandonment sequences, post-purchase campaigns, and win-back series. All FDA-compliant but still conversion-focused.
Paid Advertising:
We launched Meta and Google campaigns using our compliance framework. No bans, no shutdowns, just profitable growth.
Operations:
We connected them with peptide-friendly payment processors, optimized their manufacturing to reduce costs by 35%, and set up proper regulatory compliance.
The results:
$1.1M from email alone (using Omnisend)
$2.2M total revenue (7x growth)

11.09x ROAS on Meta ($896,520 revenue from $80,840 spend)
Zero account bans or compliance issues

But here's the crazy part: this isn't even our best-performing client. It's just the one I can share numbers for.
The Infrastructure Nobody Else Provides
Here's what makes Spring Peptides different from every other agency or service provider:
Marketing (40% of what we do):
• Compliant Meta/Google advertising that doesn't get banned
• Email marketing with peptide-friendly ESPs
• Regulatory-compliant copy that still converts
• Creative that educates without making prohibited claims
Business Infrastructure (60% of what we do):
• Payment processing that actually works long-term
• Manufacturing optimization (we've reduced COGs by 30-50% for clients)
• Regulatory compliance and legal framework
• Supply chain management
• Exit preparation and business valuation
Most peptide brands think they need marketing help, but what they actually need is someone who can solve every operational challenge preventing them from scaling.
We have partnerships with peptide-friendly payment processors, we know which ESPs actually work for this industry, and we have compliance frameworks that keep accounts safe while still driving conversions.
Most importantly, we understand that marketing is just one piece of the puzzle. The real value comes from solving all the operational challenges that prevent scaling.
Why This Opportunity Is Massive
Think about it: you have an industry with exploding demand but almost no competition because most businesses can't figure out how to operate in this space.
The peptide brands that solve these infrastructure challenges in the next 12-24 months will dominate their market for the next decade. While their competitors are still getting banned from advertising platforms, these brands will be scaling to eight and nine figures.
We're not just helping brands with marketing, we're helping them build moats that their competitors can't cross.
The $2,500 Opportunity
Here's why I'm telling you all this: there's probably someone in your network who runs a peptide brand or knows someone who does.
If you can connect us with a peptide brand that we end up working with, we'll pay you $2,500 as a referral fee. One-time payment, no strings attached.
But honestly, the money isn't the main reason I'm sharing this. The main reason is that if you know someone struggling with these challenges, you'd genuinely be helping them solve problems that are probably keeping them up at night.
Every peptide brand owner I talk to has the same story: "I have great products and customers who love them, but I can't scale because every platform shuts me down."
We've solved that problem, and the results speak for themselves.
See you next Thursday,
Arik